🇺🇸 FDA
Patent

US 6933113

Modulation of endogenous gene expression in cells

expired A61KA61K48/00A61K48/005

Quick answer

US patent 6933113 (Modulation of endogenous gene expression in cells) held by Sangamo Biosciences, Inc. expires Mon Aug 18 2025 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Sangamo Biosciences, Inc.
Grant date
Tue Aug 23 2005 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 18 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
33
CPC classes
A61K, A61K48/00, A61K48/005, A61P, A61P11/00